Global Intranasal Drug Delivery Market: Overview
Drug delivery mainly refers to a method of delivering a drug/medicine into the body to have an effective therapeutic effect. Various methods are majorly utilized for the delivery of the drug. Pulmonary and nasal routes are considered to be the most popular types for delivering the drug.
Global Intranasal Drug Delivery Market: Growth Factors
High prevalence of cardiovascular diseases, patent expiration of popular drugs, increased cases of cancer and diabetes, implementation of self-administration practices, increased focus on pediatric and elderly patients, and rising demand for home healthcare devices are some of the most important aspects propelling the intranasal drug delivery systems market expansion across the world. Other aspects that are expected to fuel this market comprise rapid R&D and acceptance of new drug delivery methods and devices, reformulation of injections and oral drugs into the formulations to be checked by nasal route, and fast onset of action. The global intranasal drug delivery market is projected to increase at a major rate owing to growing R&D in the field and the high implementation rate for delivery mode. Furthermore, enhancement in the reimbursement situation is fuelling the global intranasal drug delivery market.
On the other hand, drug formulation stoppage and market recalls, as well as technical obstruction may act as a restraint to the development of this market. Moreover, high price involved and lack of expert medical professionals are also few of the most important aspects that are restraining the global intranasal drug delivery market.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Global Intranasal Drug Delivery Market: Segmentation
In terms of device type, the intranasal drug delivery market can be categorized into ointments & solutions and nasal sprays. In terms of therapeutic applications, the intranasal drug delivery market can be fragmented into allergic infections, analgesic, osteoporosis, pain management, vaccines, and sexual dysfunction.
Global Intranasal Drug Delivery Market: Regional Analysis
North America is expected to dominate and lead the global intranasal drug delivery market owing to growing implementation of nasal form for delivering the drug as well as better healthcare facilities in the province. In addition, several government initiatives and rise in the awareness rate among the individuals are some of the significant aspects fuelling the global intranasal drug delivery market. The Asia Pacific is likely to be followed by Europe. India and China are projected to be the fastest developing market for intranasal drug delivery in the Asia Pacific. This is owing to the huge investments made by different key companies in these regions. Some of the significant driving factors for the global intranasal drug delivery market in up-coming countries are the huge pool of patients, increasing government funding, and development in the medical facilities.
Global Intranasal Drug Delivery Market: Competitive Players
Some of the most important market players in the global intranasal drug delivery market are Alza Corporation, Aegis Therapeutics LLC, MedImmune, Inc., AstraZeneca Plc., Becton, Dickinson and Company, Baxter International, Inc., Johnson & Johnson, Inc., GlaxoSmithKline Plc., Merck & Co., Marina Biotech, Inc., Pfizer Inc., Rexam Plc., Valeant Pharmaceuticals International, Inc., and Novartis AG, among others.
Global Intranasal Drug Delivery Market: Regional Segment Analysis
What Reports Provides
Request the coronavirus impact analysis across industries and markets